Singapore markets closed

Nu Skin Enterprises, Inc. (NUS)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
13.28-0.20 (-1.48%)
As of 01:22PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 669.52M
Enterprise value 1.01B
Trailing P/E 19.17
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.35
Price/book (mrq)0.83
Enterprise value/revenue 0.53
Enterprise value/EBITDA 7.77

Trading information

Stock price history

Beta (5Y monthly) 1.13
52-week change 3-61.72%
S&P500 52-week change 328.04%
52-week high 335.94
52-week low 311.73
50-day moving average 312.76
200-day moving average 317.62

Share statistics

Avg vol (3-month) 3704.25k
Avg vol (10-day) 3762.67k
Shares outstanding 549.67M
Implied shares outstanding 649.67M
Float 848.9M
% held by insiders 12.16%
% held by institutions 182.12%
Shares short (30 Apr 2024) 41.58M
Short ratio (30 Apr 2024) 42.97
Short % of float (30 Apr 2024) 44.59%
Short % of shares outstanding (30 Apr 2024) 43.18%
Shares short (prior month 28 Mar 2024) 41.42M

Dividends & splits

Forward annual dividend rate 40.24
Forward annual dividend yield 41.78%
Trailing annual dividend rate 31.23
Trailing annual dividend yield 39.12%
5-year average dividend yield 44.37
Payout ratio 4917.65%
Dividend date 312 Jun 2024
Ex-dividend date 431 May 2024
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin -0.17%
Operating margin (ttm)3.82%

Management effectiveness

Return on assets (ttm)4.34%
Return on equity (ttm)-0.39%

Income statement

Revenue (ttm)1.9B
Revenue per share (ttm)38.34
Quarterly revenue growth (yoy)-13.30%
Gross profit (ttm)N/A
EBITDA 196.24M
Net income avi to common (ttm)-3.31M
Diluted EPS (ttm)-0.07
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)230.66M
Total cash per share (mrq)4.64
Total debt (mrq)673.41M
Total debt/equity (mrq)83.12%
Current ratio (mrq)2.09
Book value per share (mrq)16.30

Cash flow statement

Operating cash flow (ttm)144.03M
Levered free cash flow (ttm)145.74M